EU Joint Scientific Consultations: The 2026 Application Window and What It Demands from Evidence Teams

The European Commission's HTA Coordination Group opened a new application window for Joint Scientific Consultations (JSC) under EU Regulation 2021/2282 on 25 March 2026. JSCs provide pre-submission guidance from EU HTA bodies on evidence requirements — clinical trial design, endpoints, comparators, patient populations — before marketing authorisation. This playbook explains what JSCs are, who qualifies, what the consultation process demands, and how evidence teams should prepare their...